Clinical TrialID 7173
Effects of Prostaglandin E1 Treatment on Pyloric Wall in Newborns
NCT04496050
Pyloric Stenosis;Acquired|Congenital Heart Disease
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7173
- Evidence Id
- 7173
- Core Evidence Id
- 7173
- Source Clinical Trial Id
- 7163
- Herb2 Clinical Trial Id
- HBCT007163
- Nct Id
- NCT04496050
- Title
- Effects of Prostaglandin E1 Treatment on Pyloric Wall in Newborns
- Status
- Phase
- Study Result
- No
- Study Condition
- Pyloric Stenosis;Acquired|Congenital Heart Disease
- Study Type
- Observational
- Study Design
- Observational Model: |Time Perspective: p
- Intervention
- DRUG: Prostaglandin E1
- Intervention Allocation
- Intervention Model
- Intervention Mask
- Intervention Purpose
- Gender
- All
- Age
- Child
- Enrollment
- 20
- Outcome Measure
- Effect of prostaglandin E1 treatment on pyloric wall thickness in newborn period, It is aimed to evaluate whether there is a possible increase in pyloric wall thickness in newborn babies given Prostaglandin E1 due to any congenital heart disease., 18 months
- Sponsor Collaborator
- Hacettepe University
- Funded By
- OTHER
- Location
- Hacettepe University, Ankara, Turkey
- Other Id
- KA-19044
- Start Date
- 2019-05-06
- Primary Completion Date
- 2020-11-30
- Completion Date
- 2020-11-30
- First Posted
- 2020-08-03
- Results First Posted
- Last Update Posted
- 2020-08-03
- Study Document
- Study Protocol, https://cdn.clinicaltrials.gov/large-docs/50/NCT04496050/Prot_000.pdf
- Study Url
- https://clinicaltrials.gov/study/NCT04496050
- Title Cn
- Title En
- Effects of Prostaglandin E1 Treatment on Pyloric Wall in Newborns
- Bilingual Status
- semi_complete